Embed Size (px)
Citation preview
»Master of Disaster«State of the Art Therapy andComplication Management inGynecologic Oncology and Breast Cancer
LIMITED AUDIENCE IN ESSEN + ONLINE
www.masterofdisaster.org
ONLINE = FREE
September 3–5, 2020Essen, Germany
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
. . . . . . . . . . . . 5
. . . . . . . . . . . . . . . . 7 . . . . . . . . . . . . . 10
. . . . . . . . . . . . . . 12
. . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
. . . . . . . . . . . . . . . . 16
. . . . . . . . . . . . . . . . 18
Grußwort
VorprogrammDonnerstag, 3. September 2020
HauptprogrammFreitag, 4. September 2020Samstag, 5. September 2020
Referenten und Diskutanten
Anmeldung
Allgemeine Informationen
Sponsoren und Aussteller
TABLE OF CONTENTINHALT
2
Greeting Words
Pre-ProgramThursday, September 3, 2020
Main ProgramFriday, September 4, 2020Saturday, September 5, 2020
Speakers and Discussants
Registration
General Information
Sponsors and Exhibitors
. . . . . . . . . . . . . . . . . . . . . . . . . 3
. . . . . . . . . . . . . . 5
. . . . . . . . . . . . . . . . 7 . . . . . . . . . . . . . 10
. . . . . . . . . . . . . . . . 12
. . . . . . . . . . . . . . . . . . . . . . . . . . . 15
. . . . . . . . . . . . . . . . . . . . 16
. . . . . . . . . . . . . . . . . 18
GREETING WORDS
Dear Colleagues,
Coming up for the seventh time in September 2020:»Master of Disaster«. Due to Covid-19, we have modified ourformat this year: We cordially invite you to come to Essen(limited number of seats) – or to partcipate ONLINE. Theonline participation is FREE OF CHARGE.
After last years’ great success, we continue the course of ourinternational symposium. The pre-program – consisting of theworkshops Gynecologic Oncology and Breast Surgery – will beavailable on demand from Thursday on.In the main program on Friday and Saturday, outstandingrepresentatives from our international and nationalcooperation partners will give their lectures (also recorded).Afterwards, we will discuss the topics live in the auditoriumin Essen.
We are looking forward to welcoming you in person in Essen –as well as online.
Yours sincerely,
GRUSSWORT
3
Prof. Dr. med. Sherko Kümmel PD Dr. med. Philipp Harter
Prof. Dr. med. Dr. h.c. Andreas du Bois
GREETING WORDSGRUSSWORT
4
Liebe Kolleginnen und Kollegen,
zum siebten Mal heißt es im September 2020 wieder:»Master of Disaster«. Aufgrund Covid-19 ändern wir diesesJahr unser Format: Wir laden Sie ganz herzlich sowohl nachEssen ein (limitierte Plätze) – als auch zur Teilnahme ONLINE.Die Teilnahme online ist KOSTENFREI.
Nach all den erfolgreichen Jahren setzen wir den Kurs unseresinternationalen Symposiums fort. Das Vorprogramm – dieWorkshops der Gynäkologischen Onkologie und derBrustchirurgie – werden Ihnen als aufgezeichnete Vorträgeab Donnerstag on demand zur Verfügung gestellt.Im Hauptprogramm am Freitag und Samstag referieren dannherausragende Vertreter unserer internationalen undnationalen Kooperationspartner. Im Anschluss an die(ebenfalls aufgezeichneten) Vorträge diskutieren wir imEssener Auditorium live die Inhalte.
Wir würden uns freuen, Sie persönlich in Essen wie auchonline begrüßen zu dürfen.
Herzlichst Ihre
Prof. Dr. med. Sherko Kümmel PD Dr. med. Philipp Harter
Prof. Dr. med. Dr. h.c. Andreas du Bois
PRE-PROGRAMVORPROGRAMM
5
THURSDAY, SEPTEMBER 3, 2020
BREAST SURGERY WORKSHOPON DEMAND
ALCL
20 min. Keynote Lecture ALCL – The Change of a Daily Routine P. Cordeiro, New York, NY (USA)
15 min. Radiologic Diagnosis of ALCL Ultrasound: A. Kümmel, Essen (D)
MRI, PET-CT: B. Gomez, Essen (D)
10 min. Surgery in Case of Possible ALCL – The European View M. Thill, Frankfurt/Main (D)
10 min. Change from Textured to Smooth Surfaced Implants: First Results S. Kümmel, Essen (D)
STATEMENTS, PICTURE AND VIDEO LESSONS
20 min. Keynote Lecture OPBC: Oncoplastic Breast Consortium – What are the Unmet Needs for the Future in Oncoplastic Breast Surgery? W. Weber, Basel (CH)
10 min. Anatomic Preparation in NSM: Identification of Superficial Fascia First Results in Oncological Safety and Cosmesis S. Kümmel, Essen (D)
10 min. Pre- or Subpectoral Implant Reconstruction after Mastectomy – Is There a Gold Standard? J. Heil, Heidelberg (D)
10 min. Breast Surgery – Discussion S. Kümmel, Essen (D) F. Reyal, Paris (F) W. Weber, Basel (CH) B. Behr, Essen (D)
PRE-PROGRAMVORPROGRAMM
SURGICAL WORKSHOPGYNECOLOGIC ONCOLOGYON DEMAND
30 min. Plastic Reconstruction in Vulvar Cancer Surgery S. Prader Brixen (I)
30 min. Technique of Pelvic En-bloc Resection S. Schneider, Essen (D)
30 min. Diaphragm Surgery in Ovarian Cancer T. Baert, Essen( D)
30 min. Peri-operative Fluid Management for Ovarian Cancer Surgery – the Anesthesiologist’s Perspective A. Feldheiser, Essen (D)
30 min. Management of Bowel Anastomosis A. du Bois, Essen (D)
30 min. Technique, Indication and Postoperative Management of Splenectomy C. Grimm, Wien (A)
30 min. Technique and Indication for Lymphadenectomy in Ovarian Cancer B. Ataseven, Essen (D)
30 min. Endoscopic Para-aortic Lymphadenectomy F. Lécuru, Paris (F)
6
MAIN PROGRAMHAUPTPROGRAMM
7
FRIDAY, SEPTEMBER 4, 2020
GYNECOLOGIC ONCOLOGYLIVE ON TAPE AND LIVE-DISCUSSION
PANELModerators: A. du Bois, Essen (D); P. Harter, Essen (D)Discussants: L. Chiva de Agustin, Madrid (E);N. Colombo, Milano (I), A. González Martín, Madrid (E)
MANAGEMENT OF RECURRENT OVARIAN CANCER
12.00–12.15 pmOngoing Trials in Gynecologic OncologyF. Hilpert, Hamburg (D)
12.15–12.30 pmDESKTOP III – A Practice Changer?A. du Bois, Essen (D)
12.30–12.45 pmSOC-1, GOG213 and DESKTOP III:Why is GOG 213 Negative?D. Chi, New York, NY (USA)
12.45–1.00 pmLive Discussion and Live ChatSurgery of Recurrent Ovarian Cancer –A New Standard?
1.00–1.20 pm„Platinum-sensitive“ is Outdated –What Means „Platinum is an Option“?J. Ledermann, London (UK)
1.20–1.50 pm: BREAK and EXHIBITOR TALK
AN UPDATE ON ASSESSMENT AND DIAGNOSTICS
1.50–2.05 pmPitfals in Sentinel DiagnosticsN. Abu-Rustum, New York, NY (USA)
2.05–2.20 pmHow Reliable is Preoperative Imaging Today?Ready to Build Strategic Decisions on It?T. van Gorp, Leuven (B)
LIVE
8
MAIN PROGRAMHAUPTPROGRAMM
2.20–2.35 pmTechnique and Role of Laparoscopic Assessment inGynecologic OncologyA. Fagotti, Roma (I)
2.35–2.55 pmLive Discussion and Live Chat
FOCUS ON CERVICAL CANCER
2.55–3.10 pmUterus Preserving Therapy in Cervical CancerN. Colombo, Milano (I)
3.10–3.15 pmLive Discussion and Live Chat
3.15–3.45 pmRisk Factors and Management of Fistula in GynecologicalOncology Surgery} Urinary Tract Fistula (3.15–3.30 pm)
C. Fotopoulou, London (UK) + Berlin (D)} Bowel Fistula (3.30–3.45 pm)
P. Alesina, Essen (D)
3.45–4.00 pmManagement of Bladder Dysfunction After Radical PelvicSurgeryG. Aletti, Milano (I)
4.00–4.15 pmLive Discussion and Live Chat
4.15–4.45 pm: BREAK and EXHIBITOR TALK
FRAILTY, WOUND HEALING AND MISCELLANEOUS
4.45–5.00 pmHow to Identify Fragility and Resilence Before RunningInto a Disaster and How to Manage It?J. Sehouli, Berlin (D)
5.00–5.15 pmWound Healing Disorders – After VulvectomyS. Mahner, München (D)
5.15–5.30 pmWound Healing Disorders – After Laparotomy/AbdomenApertumM.Z. Muallem, Berlin (D)
LIVE
LIVE
LIVE
9
MAIN PROGRAMHAUPTPROGRAMM
5.30–5.45 pmLive Discussion and Live Chat
UPDATE ON SYSTEMIC TREATMENT IN GYNECOLOGICONCOLOGY
5.45–6.00 pmKeynote LectureSystemic Therapy in Primary Ovarian Cancer: Bevacizumaband/or PARPi or Both? Ready for Primetime?A. González Martín, Madrid (E)
6.00–6.15pmRisk-adapted Therapy Planning: Upfront Surgery orChemotherapy First?L. Chiva de Augustin, Madrid (E)
6.15–6.30 pmUpdate on HIPEC: Is There Already a Role Outside ClinicalTrials?G. Scambia, Roma (I)
6.30–6.45 pmLive Discussion and Live Chat
LIVE
LIVE
MAIN PROGRAMHAUPTPROGRAMM
SATURDAY, SEPTEMBER 5, 2020
BREAST CANCERLIVE ON TAPE AND LIVE DISCUSSION
CHAIRS. Kümmel, Essen (D); O. Gluz, Mönchengladbach (D)
UPDATE ON SYSTEMIC TREATMENT IN BREAST CANCER
9.00–10.00 amBreast Cancer – What is Proven, What is Coming Next?From Early to Metastatic Disease} Triple Negative (9.00–9.20 am)
P. Schmid, London (UK)} HER2 Overexpression (9.20–9.40 am)
J. Cortes, Madrid (E) + Barcelona (E)} De-Escalation (9.40–10.00 am)
O. Gluz, Möchengladbach (D)
10.00–10.15 amLive Discussion and Live ChatChair
LOCAL THERAPY – SOLUTIONS FOR COMPLICATIONS
10.15–10.25 amIs Radiation of 1–2 Weeks Possible in Breast Cancer?R. Galalae, Wien (A)
10.25–10.35 amRadiotherapy and Implants (Thoracic Wall Radiation inpN+ or Only LAW etc.)K. Ferentinos, Limassol (CY)
10.35–10.45 amSurgery after Complications – From Infection to NecrosisF. Reyal, Paris (F)
10.45–11.00 pmJoint Lecture: Integrative Oncology in Case of SurgicalComplicationsG. Dobos, Essen (D)
11.00–11.20 am:Live Discussion and Live ChatChair + Discussants: R. Galalae, Wien (A);F. Reyal, Paris (F)
10
LIVE
LIVE
11
MAIN PROGRAMHAUPTPROGRAMM
11.20–11.40 am: BREAK and EXHIBITOR TALK
LOCAL THERAPY – AXILLA SURGERY
11.40 am – 12.10 pmManagement: Clinical Lymph Node Positive Situations inthe Era of Post-neoadjuvant Approaches} SENTA Trial: Final Results (11.40–11.50 am)
M. Reinisch, Essen (D)} Institute Curie Experience (11.50–12.00)
F. Reyal, Paris (F)} MD Anderson Experience (12.00–12.10 pm)
A. Caudle, Houston TX (USA)
12.10–12.20 pmNew Ideas – Ongoing Trials in EuropeW. Weber, Basel (CH)
12.20–12.35 pmLive Discussion and Live ChatChair + Discussants: F. Reyal, Paris (F);W. Weber, Basel (CH)
RECONSTRUCTIVE SURGERY
12.35–12.50 pmPRO: We Need Meshes/ADMs in Subcutaneous ImplantReconstructionD. Gschwantler-Kaulich, Wien (A)
12.50–1.05 pmCONTRA: We Do Not Need Meshes/ADMs in SubcutaneousImplant ReconstructionS. Potter, Bristol (UK)
1.05–1.15 pmFlap Reconstruction: Where DIEP is Not Possible (TMG, FCI,LICAP etc.)B. Behr, Bochum (D)
1.15–1.30 pmLive Discussion and Live ChatChair + Discussants: B. Behr, Bochum (D);F. Reyal, Paris (F)
LIVE
LIVE
12
SPEAKERS AND DISCUSSANTSREFERENTEN UND DISKUTANTEN
Abu-Rustum, Prof. Dr. Nadeem R., Gynecology Service,Department of Surgery, Memorial Sloan Kettering CancerCenter, New York, NY (USA)
Alesina, Dr. med. Pier F., Department of Surgery, Evang.Kliniken Essen-Mitte, Essen (D)
Aletti, Dr. Giovanni, Innovative Therapeutic Strategies inOvarian Cancer Unit, IEO, Milano (I)
Ataseven, PD Dr. med. Beyhan, Department of Gynecologyand Gynecologic Oncology, Evang. Kliniken Essen-Mitte,Essen (D)
Baert, Dr. med. Thais, Department of Gynecology andGynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D)
Behr, Prof. Dr. med. Björn, Department of Surgery, Evang.Kliniken Essen-Mitte, Essen (D)
du Bois, Prof. Dr. med. Dr. h.c. Andreas, Department ofGynecology and Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D)
Caudle, Dr. Abigail S., Department of Breast SurgicalOncology, Houston, Texas (USA)
Chi, Dr. Dennis S., Gynecology Service, Department of Surgery,Memorial Sloan Kettering Cancer Center, New York, NY (USA)
Chiva de Agustin, Dr. Luis, Department of Obstetrics andGynecology, Clinica Universidad de Navarra, Madrid (E)
Colombo, Prof. Dr. Nicoletta, Department of Medicine andSurgery, Università Milano-Bicocca, European Institute ofOncology, Milano (I)
Cordeiro, Dr. Peter G., Department of Surgery, MemorialSloan Kettering Cancer Center, New York, NY (USA)
Cortes, Dr. Javier, IOB Institute of Oncology, Madrid andBarcelona (E)
Dobos, Prof. Dr. med. Gustav J., Evang. Kliniken Essen-Mitte,Essen (D)
Fagotti, Prof. Anna, Gynecology and Obstetrics, CatholicUniversity of the Sacred Heart, Roma (I)
Feldheiser, PD Dr. med. Aarne, Evang. Department forAnesthesiology, Intensive Care and Pain Therapy, KlinikenEssen-Mitte, Essen (D)
Ferentinos, Dr. Konstantinos, Department of RadiotherapyOncology, German Oncology Center, Limassol (CY)
SPEAKERS AND DISCUSSANTSREFERENTEN UND DISKUTANTEN
13
Fotopoulou, Prof. Dr. med. Christina, Department ofGynecology with Center for Oncological Surgery, Charité –Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D) + Obstetrics and Gynecology, GynecologicOncology, Hammersmith Hospital, Queen Charlotte’s andChelsea Hospital, London (UK)
Galalae, Razvan, MD, PhD, Interventional Particle Therapy,EBG MedAustron, Wien (A)
Gluz, PD Dr. med. Oleg, Breast Center Niederrhein,Evangelisches Krankenhaus Bethesda, Mönchengladbach (D)
Gomez, Dr. med. Benedikt, Interdisciplinary Breast Center,Evang. Kliniken Essen-Mitte, Essen (D)
González Martín, Dr. Antonio, Department of MedicalOncology, Clinica Universidad de Navarra, Madrid (E)
Van Gorp, Prof. Dr. Toon, Gynecology and Obstetrics, UZLeuven, Campus Gasthuisberg, Leuven (B)
Grimm, Prof. PD Dr. med. Christoph, Department ofGynecology and Gynecologic Oncology, Universitätsklinik fürFrauenheilkunde, Medizinische Universität, Wien (A)
Gschwantler-Kaulich, Assoc. Prof. Priv.-Doz. Dr. Daphne,Department of Gynecology and Gynecologic Oncology,Universitätsklinik für Frauenheilkunde, MedizinischeUniversität, Wien (A)
Harter, PD Dr. med. Philipp, Department of Gynecology andGynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen (D)
Heil, Prof. Dr. med. Jörg, Breast Center, Women’s Health andObstetrics, Universitätsklinikum Heidelberg, Heidelberg (D)
Hilpert, Prof. Dr. med. Felix, Mamma Center Hamburg,Krankenhaus Jerusalem, Hamburg (D)
Kümmel, Dr. med. Aylin, Interdisciplinary Breast Center,Evang. Kliniken Essen-Mitte, Essen (D)
Kümmel, Prof. Dr. med. Sherko, Interdisciplinary BreastCenter, Evang. Kliniken Essen-Mitte, Essen (D)
Lecuru, Prof. Fabrice, Breast, gynecology and reconstructivesurgery unit, Curie Institute; University of Paris, Faculty ofMedicine, Paris (F)
Ledermann, Prof. Dr. Jonathan, UCL Cancer Institute,University College London, London (UK)
Mahner, Prof. Dr. med. Sven, Women’s Health andObstetrics, Universitätsklinikum München, Campus Innenstadt,München (D)
SPEAKERS AND DISCUSSANTSREFERENTEN UND DISKUTANTEN
Muallem, Dr. med. Dr. med. (syr) Mustafa Zelal, Departmentof Gynecology and Oncologic Surgery, Charité –Universitätsmedizin Berlin, Berlin (D)
Potter, Dr. Shelley, Bristol Breast Care Centre, SouthmjeadHospital, Bristol (UK)
Prader, Dr. med. univ. Sonia, Department of Gynecology,Hospital Brixen, Brixen (I)
Reinisch, Dr. med. Mattea, Interdisciplinary Breast Center,Evang. Kliniken Essen-Mitte, Essen (D)
Reyal, Prof. Fabien, Department of Breast Cancer, GynecologicCancer and Reconstructive Surgery, Université Paris Descartes,Paris (F)
Scambia, Prof. Giovanni, Gynecology and Obstetrics, CatholicUniversity of the Sacred Heart, Roma (I)
Schmid, Prof. Dr. med. Peter, Barts Cancer Institute, Centre ofExcellence Queen Mary University, London (UK)
Schneider, Dr. med. Stephanie, Department of Gynecologyand Gynecologic Oncology, Evang. Kliniken Essen-Mitte,Essen (D)
Sehouli, Prof. Dr. med. Dr. h.c. Jalid, Department ofGynecology with Center for Oncological Surgery, Charité –Universitätsmedizin Berlin, Campus Virchow-Klinikum,Berlin (D)
Thill, Prof. Dr. med. Marc, Department of Gynecology andGynecologic Oncology, Agaplesion Markus Krankenhaus,Frankfurt/Main (D)
Weber, Prof. Dr. med. Walter Paul, Breast Center,Universitätsspital, Basel (CH)
14
REGISTRATIONANMELDUNG
15
ONLY THIS YEAR:»MASTER OF DISASTER« ONLINE
Register now for free access to:} Pre-Program: Workshops on Gynecologic} Oncology and Breast Surgery (on demand)
on Thursday, September 3, 2020} Main Program: Lecture Sessions (live on
tape) followed by Live Discussions in Essenon Friday and Saturday, September 4–5, 2020
www.masterofdisaster.org � Registration
NUR DIESES JAHR:»MASTER OF DISASTER« ONLINE
Melden Sie sich jetzt an für einen freien Zugang:} Vorprogram: Workshops zu Gynäkologischer Onkologie
und Brustchirurgie (on demand)am Donnerstag, 3. September 2020} Hauptprogram: Vortrags-Sessions („live on tape“),
gefolgt von Live-Diskussionen in Essenam Freitag und Samstag, 4.–5. September 2020
www.masterofdisaster.org � Anmeldung
ONLINE= FREE
OR JOIN US IN ESSEN:
} Main Program: Lecture Sessions (live ontape) followed by Live Discussionson Friday and Saturday, September 4–5, 2020(Limited seats! Covid-19 guidelines implemented!)
www.masterofdisaster.org � Registration
ODER SEIEN SIE IN ESSEN DABEI:
} Hauptprogram: Vortrags-Sessions („live on tape“)gefolgt von Live-Diskussionenam Freitag und Samstag, 4.–5. September 2020(Limitierte Plätze! Covid-19-Auflagen umgesetzt!)
www.masterofdisaster.org � Anmeldung
€ 75,–
GENERAL INFORMATIONALLGEMEINE INFORMATIONEN
Date ¡ DatumSeptember 3–5, 2020} September 3, 2020: Pre-program with workshops – available online (on demand) Vorprogramm mit Workshops – verfügbar online (on demand)} September 4 and 5, 2020: Main program – online (stream) from Essen; seats (limited) in the auditorium available
Hauptprogramm – online (gestreamt) aus Essen; Plätze (limitiert) im Auditorium verfügbar
Venue ¡ OrtMain program: seats (limited) available!Hauptprogramm: Plätze (limitiert) verfügbar!
Hotel FranzSteeler Straße 261, 45138 Essen (Germany)www.hotel-franz.de
Scientific Board ¡Wissenschaftliche LeitungProf. Dr. med. Sherko KümmelInterdisciplinary Breast UnitInterdisziplinäres Brustkrebszentrum
Priv.-Doz. Dr. med. Philipp HarterProf. Dr. med. Dr. h.c. Andreas du BoisDepartment of Gynecology and Gynecologic OncologyKlinik für Gynäkologie und Gynäkologische Onkologie
Evang. Kliniken Essen-Mitte, Essen (Germany)
Info, Organizer ¡ Info, VeranstalterJörg EickelerBeratung Organisation VeranstaltungNeanderstraße 20, 40233 Düsseldorf (Germany)Tel. +49(0)211/3033224, Fax +49 (0)211/[email protected], www.eickeler.org
Homepage ¡ Homepagewww.masterofdisaster.org
Social Media ¡ Soziale Medien
16
GENERAL INFORMATIONALLGEMEINE INFORMATIONEN
17
Fees ¡ GebührenMain program, September 4–5, 2020Seat in the auditorium (limited) in the Hotel Franz, EssenEUR 75,– for both days
Hauptprogramm, 4.–5. September 2020Platz im Auditorium (limitiert) im Hotel Franz, EssenEUR 75,– für beide Tage
REGISTRATION FOR ONLINE: FREE OF CHARGE!
ANMELDUNG FÜR ONLINE: GEBÜHRENFREI!
Registration ¡ AnmeldungPlease see page 15 Bitte beachten Sie Seite 15
www.masterofdisaster.org
CME Points ¡ CME-PunkteAccreditation by the Medical Association North RhineCME-Punkte durch die Ärztekammer Nordrhein
All Covid-19 guidelines will be implemented at theconference venue! ¡ Am Veranstaltungsort werdenalle Covid-19-Auflagen umgesetzt!
ONLINE= FREE
SPONSORS AND EXHIBITORSSPONSOREN UND AUSSTELLER
Roche Pharma AG79639 Grenzach-WyhlenEUR 20.000,–
AstraZeneca GmbH22880 WedelEUR 20.000,–
MSD Sharp & Dohme GmbH85540 HaarEUR 20.000,–
Teva GmbH89079 UlmEUR 10.000,–
18
Amgen GmbH80992 MünchenEUR 15.000,–
GlaxoSmithKline GmbH & Co.84675 MünchenEUR 25.000,–
Daiichi-Sankyo Deutschland GmbH81379 MünchenEUR 10.000,–
Polytech Health & Aesthetics GmbH64807 DieburgEUR 7.500,–
Medtronic GmbH40670 MeerbuschEUR 8.000,–
Lilly Deutschland GmbH61352 Bad HomburgEUR 5.000,–
Pierre Fabre Pharma GmbH79111 FreiburgEUR 5.000,–
Medac GmbH22880 WedelEUR 5.000,–
Exact Sciences Deutschland GmbH51103 KölnEUR 3.500,–
Riemser Pharma GmbH17489 GreifswaldEUR 3.500,–
Medac GmbH22880 WedelAusstellung, Sponsoring: 5.000,–
Novartis Pharma GmbH90429 NürnbergAusstellung, Sponsoring: 5.000,–
PharmaMar GmbH10623 BerlinAusstellung, Sponsoring: 5.000,–
Riemser Pharma GmbH17489 GreifswaldAusstellung, Sponsoring: 3.500,–
SPONSORS AND EXHIBITORSSPONSOREN UND AUSSTELLER
19
Eisai GmbH60528 Frankfurt/MainEUR 2.500,–
PharmaMar GmbH10623 BerlinEUR 2.000,–
Bess AG14167 BerlinEUR 1.500,–
Pfm Medical AG50996 KölnEUR 2.000,–
Somatex Medical Technologies GmbH14199 BerlinEUR 3.500,–
Erbe Elektromedizin GmbH72072 TübingenEUR 1.500,–
VIELEN DANK FÜR DIE UNTERSTÜTZUNG!
Unterstützung durch Sponsoring und Ausstellung.
Die Beiträge werden genutzt für: Veranstaltungsorganisation und Marketing;Raummiete, Technik (Websites, Contentproduktion, Veranstaltungstechnik undStreaming), Catering, Reisekosten und Honorare der Referenten.
Sysmex Deutschland GmbH22848 NorderstedtEUR 1.500,–
